-
DAPT (GSI-IX) Workflow for Notch Signaling Studies
2026-09-04
DAPT (GSI-IX) provides a rapid chemical route to perturb γ-secretase-dependent APP and Notch processing in cell, tissue-engineering, and disease-model workflows. Its most useful application is not simply pathway inhibition, but pairing a controlled dose matrix with lineage, proliferation, and substrate-specific readouts.
-
EPI-001: Rethinking AR N-Terminal Inhibition
2026-09-04
EPI-001 is an androgen receptor N-terminal domain inhibitor designed to interrogate ligand-dependent and ligand-independent AR signaling. This thought-leadership guide connects prostate cancer and TNBC evidence with practical assay design, biomarker strategy, and translational decision-making.
-
Proteinase K as an Orthogonal Protease Assay Control
2026-09-03
Proteinase K is more than a genomic DNA isolation enzyme: its broad cleavage profile can help researchers design orthogonal protease controls and interpret inhibitor assays. This article connects its biochemical behavior with the merbromin–SARS-CoV-2 3CLpro study while defining practical limits for DNA and enzymology workflows.
-
Spiroplasma eriocheiris Entry into Drosophila S2 Cells
2026-09-03
Wei and colleagues established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris enters host cells through clathrin-dependent endocytosis and macropinocytosis. The study further connects intracellular infection with actin filaments and microtubules, providing a useful framework for interpreting cytoskeletal perturbation in invertebrate host–pathogen systems.
-
ARCA EGFP mRNA (5-moUTP) Assay Guide
2026-09-02
ARCA EGFP mRNA (5-moUTP) is a polyadenylated mRNA reporter for direct EGFP detection after mRNA transfection in mammalian cells. Its ARCA cap, 5-moUTP modification, and optimized poly(A) tail are designed to improve translation consistency, transcript stability, and fluorescence-based assay reproducibility.
-
Etomoxir: From FAO Blockade to Translational Insight
2026-09-02
Etomoxir is more than a CPT-1 inhibitor: it is a strategic metabolic perturbation tool for connecting fatty acid oxidation, immune-cell function, lipid remodeling, and disease phenotypes. This thought-leadership guide shows how to deploy R-(+)-Etomoxir in standardized whole-blood, cellular, and EAE workflows while accounting for DGAT activity, irreversible inhibition, donor variability, and translational limitations.
-
Z-VDVAD-FMK: A Causal Probe of Viral Apoptosis
2026-09-01
Z-VDVAD-FMK can turn caspase inhibition into a causal test of apoptosis during Senecavirus A infection. This article explains how to combine the inhibitor with DDX23, viral-protein, and cell-death readouts while avoiding overinterpretation of caspase specificity.
-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-09-01
Wang et al. identify METTL16 as an m6A-linked suppressor of ferroptosis in hepatocellular carcinoma and define a METTL16–SENP3–LTF pathway that limits iron-dependent lipid peroxidation. By combining molecular assays, organoids, xenografts, genetically modified mice, and human samples, the study provides a mechanistic basis for investigating ferroptosis sensitization in HCC, while clinical translation remains prospective.
-
Brefeldin A: From Trafficking to Assay Design
2026-08-31
Brefeldin A is a versatile trafficking perturbant for connecting ER–Golgi disruption with ER stress, cancer-cell phenotypes, and endothelial-barrier assay design. This article translates findings on moesin-dependent endothelial injury into a rigorous framework for interpreting BFA experiments without overstating cross-domain evidence.
-
VX-765 and the Logic of Separating Cell Death
2026-08-31
Translational inflammation research increasingly depends on distinguishing inflammatory pyroptosis from transcription-linked apoptosis. This article examines how VX-765 and its active metabolite VRT-043198 can help researchers isolate caspase-1 biology while using recent RNA Pol II findings to sharpen experimental interpretation.
-
(-)-Arctigenin: MEK1 Inhibitor Guide
2026-08-30
(-)-Arctigenin is a research-grade small molecule with reported nanomolar inhibition of MEK1 and LPS-induced iNOS expression. This guide separates product specifications, pathway evidence, breast-cancer-context interpretation, and practical assay limits.
-
MOF Nanoparticles for Non-Invasive Epilepsy Neuromodulation
2026-08-29
The reference study introduces ultrasound-activated, piezoelectric MOF-based nanoparticles designed to cross the blood–brain barrier and modulate epileptic neural activity without implanted electrodes. By combining brain-targeting ligands with platinum nanoclusters, the platform links receptor-mediated delivery, localized sononeuromodulation, and regulation of neuroinflammation and oxidative stress.
-
Exo1 for Mechanistic Exocytosis Assays
2026-08-28
Exo1, also known as methyl 2-(4-fluorobenzamido)benzoate, enables rapid dissection of Golgi–ER trafficking and ARF1-dependent secretion. This article explains how to use it as a mechanistic perturbation while avoiding the common mistake of treating broad secretory blockade as selective tumor extracellular vesicle inhibition.
-
Candida EVs, Nrg1, and Candidemia
2026-08-28
The reference study identifies a concentration-dependent self-inhibitory role for Candida albicans extracellular vesicles, linking EV exposure to SKO1-dependent induction of the hyphal repressor NRG1. Genetic and mouse infection experiments connect this transcriptional circuit with reduced hyphal development, improved survival, and lower fungal burden, while also defining important limits for therapeutic interpretation.
-
Proteinase K: From DNA Prep to Translational Insight
2026-08-27
Proteinase K is more than a routine digestion reagent. This thought-leadership guide explains how its broad-spectrum serine protease activity supports high-integrity DNA workflows, enables mechanistic studies of protein cargo, and can strengthen translational investigations inspired by recent Candida albicans extracellular-vesicle research.